ALLO
Price
$4.47
Change
+$0.01 (+0.22%)
Updated
Mar 28, 6:59 PM EST
33 days until earnings call
BEAM
Price
$33.04
Change
-$0.92 (-2.71%)
Updated
Mar 28, 6:59 PM EST
39 days until earnings call
Ad is loading...

Analysis and predictions ALLO vs BEAM

Header iconALLO vs BEAM Comparison
Open Charts ALLO vs BEAMBanner chart's image
Allogene Therapeutics
Price$4.47
Change+$0.01 (+0.22%)
Volume$908.65K
CapitalizationN/A
Beam Therapeutics
Price$33.04
Change-$0.92 (-2.71%)
Volume$736.61K
CapitalizationN/A
View a ticker or compare two or three
ALLO vs BEAM Comparison Chart

Loading...

ALLODaily Signal changed days agoGain/Loss if shorted
 
Show more...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALLO vs. BEAM commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and BEAM is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (ALLO: $4.46 vs. BEAM: $33.04)
Brand notoriety: ALLO and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 43% vs. BEAM: 84%
Market capitalization -- ALLO: $754.15M vs. BEAM: $2.7B
ALLO [@Biotechnology] is valued at $754.15M. BEAM’s [@Biotechnology] market capitalization is $2.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 6 TA indicator(s) are bullish while BEAM’s TA Score has 4 bullish TA indicator(s).

  • ALLO’s TA Score: 6 bullish, 5 bearish.
  • BEAM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than BEAM.

Price Growth

ALLO (@Biotechnology) experienced а +1.83% price change this week, while BEAM (@Biotechnology) price change was -5.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

ALLO is expected to report earnings on May 01, 2024.

BEAM is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALLO with price predictions.
OPEN
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($2.7B) has a higher market cap than ALLO($754M). ALLO YTD gains are higher at: 38.941 vs. BEAM (21.381). BEAM has higher annual earnings (EBITDA): -156.47M vs. ALLO (-300.29M). BEAM has more cash in the bank: 1.19B vs. ALLO (449M). ALLO has less debt than BEAM: ALLO (95.1M) vs BEAM (173M). BEAM has higher revenues than ALLO: BEAM (378M) vs ALLO (95K).
ALLOBEAMALLO / BEAM
Capitalization754M2.7B28%
EBITDA-300.29M-156.47M192%
Gain YTD38.94121.381182%
P/E RatioN/AN/A-
Revenue95K378M0%
Total Cash449M1.19B38%
Total Debt95.1M173M55%
TECHNICAL ANALYSIS
Technical Analysis
ALLOBEAM
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 17 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
ALLODaily Signal changed days agoGain/Loss if shorted
 
Show more...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DCUSX14.220.04
+0.28%
DWS CROCI US S
DWGCX10.500.02
+0.19%
American Funds Dvlpg Wld Gr&Inc C
QABGX21.680.01
+0.05%
Federated Hermes MDT Balanced A
POGCX47.44-0.09
-0.19%
Putnam Large Cap Growth C
LIGCX9.72-0.02
-0.21%
Loomis Sayles International Growth C

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with NTLA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
N/A
NTLA - ALLO
61%
Loosely correlated
+1.67%
BEAM - ALLO
55%
Loosely correlated
-2.71%
ATAI - ALLO
49%
Loosely correlated
+10.06%
DNLI - ALLO
49%
Loosely correlated
-1.30%
EDIT - ALLO
48%
Loosely correlated
-0.27%
More

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with NTLA. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-2.71%
NTLA - BEAM
77%
Closely correlated
+1.67%
DNLI - BEAM
68%
Closely correlated
-1.30%
VERV - BEAM
63%
Loosely correlated
+0.68%
EDIT - BEAM
63%
Loosely correlated
-0.27%
PRME - BEAM
62%
Loosely correlated
+3.48%
More